Back to trial detailsIntake questionnaire
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Applying to University of Kansas Cancer Center - North · Kansas City, Missouri
Answer a few short questions to share with the research team.
0 of 4 answered